Medicare billing address
CMS Medicare provider billing file
3838 Massillon RdUniontown, OH 44685
CMS public data · NPI 1215015870
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Timothy J Carrabine, MD
Specialty
Credential
MD
NPI
1215015870
Primary source state
OH
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Timothy J Carrabine, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
3838 Massillon RdCMS Doctors & Clinicians file
3838 Massillon RdIn the 2024 CMS provider billing file, this NPI had 88 Medicare beneficiaries and 68,151 total services. The average beneficiary age was 63, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$2,274,676.54
Total Medicare payment amount
$1,809,265.80
Medicare beneficiaries
88
Total services
68,151
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
55%
CMS beneficiary-panel share
Hypertension
53%
CMS beneficiary-panel share
Anxiety
40%
CMS beneficiary-panel share
Depression
38%
CMS beneficiary-panel share
Mood disorders
38%
CMS beneficiary-panel share
Chronic kidney disease
17%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, natalizumab, 1 mg | 44,707 | $21.55 |
| Injection, ocrelizumab, 1 mg | 22,804 | $55.95 |
| Administration of chemotherapy into vein, each additional hour | 159 | $24.26 |
| Administration of chemotherapy into vein, 1 hour or less | 128 | $106.17 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 92 | $117.00 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 87 | $56.53 |
| Injection, methylprednisolone sodium succinate, 5 mg | 56 | $0.29 |
| Injection of additional new drug or substance into vein | 53 | $13.19 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 49 | $5.79 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 13 | $80.24 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1215015870. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Baclofen | Baclofen | 404 | 633 | $7,694.61 |
| 2 | Gabapentin | Gabapentin | 215 | 409 | $5,681.15 |
| 3 | Tizanidine Hcl | Tizanidine Hcl | 144 | 238 | $1,430.20 |
| 4 | Kesimpta Pen | Ofatumumab | 120 | 122 | $1,104,252.88 |
| 5 | Clonazepam | Clonazepam | 119 | 135.5 | $536.00 |
| 6 | Copaxone | Glatiramer Acetate | 104 | 110.3 | $608,902.68 |
| 7 | Glatiramer Acetate | Glatiramer Acetate | 91 | 98.1 | $214,715.33 |
| 8 | Teriflunomide | Teriflunomide | 83 | 91 | $220,382.00 |
| 9 | Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 74 | 74 | $2,021.17 |
| 10 | Duloxetine Hcl | Duloxetine Hcl | 54 | 90 | $848.22 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Creighton University School Of Medicine
Graduation year
1985
Group/practice field
The Oak Clinic
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.